The U.S. Department of Justice (DOJ) has reportedly rejected Amedisys’ (Nasdaq: AMED) and UnitedHealth Group’s (NYSE: UNH) attempt to divest assets, a move meant to quell antitrust concerns related to their planned merger. On Monday, reports emerged that Amedisys’ and UnitedHealth’s plan to divest home health and hospice centers to the Pennant Group (Nasdaq: PNTG) […]
Amedisys
For those who have been following the U.S. Department of Justice’s (DOJ) legal battle against UnitedHealth Group (NYSE: UNH) and Amedisys Inc. (NASDAQ: AMED), the latest chapter was revealed last month. The DOJ and the two organizations will go to mediation in August. And even more news has since broken, with the announcement last week […]
Amedisys (Nasdaq: AMED) announced on Thursday that the company has reached agreements to divest home health and hospice care centers to affiliates of the Pennant Group (Nasdaq: PNTG) and BrightSpring Health Services (Nasdaq: BTSG). The news comes four months after Amedisys and UnitedHealth Group (NYSE: UNH) halted plans to divest more than 100 home health […]
Amedisys (Nasdaq: AMED) exceeded Wall Street expectations in its first-quarter results for 2025. The company’s home health segment benefited from increased volume and higher rates, while its high-acuity care segment reached a milestone with record admissions. However, Amedisys stock remained relatively flat amid ongoing scrutiny of the Baton Rouge, Louisiana-based company’s proposed merger with UnitedHealth […]
Headwinds primarily associated with Medicare Advantage (MA) and care activity in its insurance business led UnitedHealth Group (UHG) (NYSE: UNH) to lower its anticipated earnings per share for 2025. In the first quarter of 2025, UHG’s revenues increased by $9.8 billion year-over-year, reaching $109.6 billion. This growth was primarily driven by a more comprehensive approach […]
The U.S. Department of Justice’s (DOJ) lawsuit against Amedisys Inc. (NASDAQ: AMED) and UnitedHealth Group (NYSE: UNH) will go to mediation on Aug. 18. The DOJ sued the two companies starting in November of last year to block the UnitedHealth Group subsidiary Optum from acquiring Amedisys due to antitrust concerns. The case will now go […]
Addressing social determinants of health (SDoH) is becoming increasingly important due to new regulations from the Centers for Medicare & Medicaid Services (CMS) and the shift toward value-based care payment models. With ongoing staffing shortages and a growing demand for home-based care services, social workers are taking on greater responsibilities to support the health care […]
In December 2024, BrightStar Care Founder Shelly Sun Berkowitz was within 10 days of closing a deal to sell the company, when she decided to step away. “It just didn’t feel right,” she told me this week. “I didn’t feel like I was going to have the voice I wanted to have, I didn’t feel […]
Amedisys Inc. (Nasdaq: AMED) experienced growth in home health during the fourth quarter of 2024, despite incurring merger-related costs from its pending acquisition by UnitedHealth Group (NYSE: UNH). The company’s home health business reported net service revenues of $377 million for the fourth quarter of 2024, an increase from $358.9 million in the same quarter […]
Recent developments in the legal battle over the planned $3.3 billion UnitedHealth Group (NYSE: UHG) acquisition of Amedisys (Nasdaq: AMED) have moved the case closer to trial and shed more light on how UnitedHealth and Amedisys are pursuing divestments and defending the transaction. First, UnitedHealth dropped its motion to dismiss the case, saying that the […]
Subscribe
Receive industry updates and breaking news from HHCN